SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Multiple C-suite executives at Vir Biotechnology, including the CEO,…

Vir Biotechnology, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 5/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Multiple C-suite executives at Vir Biotechnology, including the CEO, CFO, and General Counsel, conducted open-market share sales over the past week, totaling $404,942 in sales proceeds. These transactions coincide with a routine grant of stock awards worth $0 in value. The selling represents modest insider divestment by top executives.

  • CEO Marianne De Backer sold 33,801 shares for $282,614 in open-market transactions.
  • CFO Jason O'Byrne and General Counsel Vanina de Verneuil each sold 2,089 and 21,262 shares, respectively, netting $15,569 and $197,375 total.
  • Five C-suite insiders sold shares in open market, aggregating $404,942 in total proceeds.
  • All sales occurred between $7.45 and $9.82 per share, with higher prices on later dates.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access